WO2006003519A3 - Use of emulsions for intra: and periocular injection - Google Patents

Use of emulsions for intra: and periocular injection Download PDF

Info

Publication number
WO2006003519A3
WO2006003519A3 PCT/IB2005/002317 IB2005002317W WO2006003519A3 WO 2006003519 A3 WO2006003519 A3 WO 2006003519A3 IB 2005002317 W IB2005002317 W IB 2005002317W WO 2006003519 A3 WO2006003519 A3 WO 2006003519A3
Authority
WO
WIPO (PCT)
Prior art keywords
intra
emulsions
periocular injection
periocular
injection
Prior art date
Application number
PCT/IB2005/002317
Other languages
French (fr)
Other versions
WO2006003519A2 (en
Inventor
Kosak Yvonne De
Gregory Lambert
Simon Benita
Patrick Couvreur
Francine Behar-Cohen
Catherine Dubernet
Laura Rabinovich-Guilatt
Original Assignee
Novagali Pharma Sa
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Univ Jerusalem Yissum Res Dev
Kosak Yvonne De
Gregory Lambert
Simon Benita
Patrick Couvreur
Francine Behar-Cohen
Catherine Dubernet
Laura Rabinovich-Guilatt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04291684A external-priority patent/EP1611879B1/en
Application filed by Novagali Pharma Sa, Centre Nat Rech Scient, Inst Nat Sante Rech Med, Univ Jerusalem Yissum Res Dev, Kosak Yvonne De, Gregory Lambert, Simon Benita, Patrick Couvreur, Francine Behar-Cohen, Catherine Dubernet, Laura Rabinovich-Guilatt filed Critical Novagali Pharma Sa
Publication of WO2006003519A2 publication Critical patent/WO2006003519A2/en
Publication of WO2006003519A3 publication Critical patent/WO2006003519A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Abstract

Use of a composition comprising an emulsion and optionally at least a pharmaceutical active ingredient for the manufacture of a medicament in a form adapted for intra- and periocular administration.
PCT/IB2005/002317 2004-07-02 2005-07-01 Use of emulsions for intra: and periocular injection WO2006003519A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04291684.1 2004-07-02
EP04291684A EP1611879B1 (en) 2004-07-02 2004-07-02 Use of emulsions for intra- and periocular injection
US10/891,452 2004-07-15
US10/891,452 US20060002963A1 (en) 2004-07-02 2004-07-15 Use of emulsions for intra and periocular injections

Publications (2)

Publication Number Publication Date
WO2006003519A2 WO2006003519A2 (en) 2006-01-12
WO2006003519A3 true WO2006003519A3 (en) 2006-08-24

Family

ID=35783217

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/002317 WO2006003519A2 (en) 2004-07-02 2005-07-01 Use of emulsions for intra: and periocular injection

Country Status (1)

Country Link
WO (1) WO2006003519A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2675269T3 (en) * 2011-11-15 2018-07-10 Allergan, Inc. Treatable autoclavable suspensions of cyclosporin A form 2
WO2023031277A1 (en) 2021-08-31 2023-03-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the treatment of ocular rosacea

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018852A1 (en) * 1992-03-16 1993-09-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oil-in-water emulsions of positively charged particles
EP1020194A1 (en) * 1997-10-01 2000-07-19 Wakamoto Pharmaceutical Co., Ltd. O/w emulsion compositions
WO2002009667A2 (en) * 2000-07-28 2002-02-07 Pharmasol Gmbh Dispersions for formulating slightly or poorly soluble active ingredients
WO2002074196A1 (en) * 2001-03-15 2002-09-26 The United States of America, represented by The Secretary, Department of Health & Human Services Ocular therapeutic agent delivery devices and methods for making and using such devices
US20030018044A1 (en) * 2000-02-18 2003-01-23 Peyman Gholam A. Treatment of ocular disease
WO2003053405A1 (en) * 2001-11-01 2003-07-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method and composition for dry eye treatment
WO2003068253A1 (en) * 2002-02-14 2003-08-21 Merck Patent Gmbh Methods and compositions for the treatment of eye diseases
WO2004043480A2 (en) * 2002-11-07 2004-05-27 Peyman Gholam A Intraocular administration of cyclosporin a for the treatment of macular degeneration, retinopathy or retinitis pigmentosa

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018852A1 (en) * 1992-03-16 1993-09-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oil-in-water emulsions of positively charged particles
EP1020194A1 (en) * 1997-10-01 2000-07-19 Wakamoto Pharmaceutical Co., Ltd. O/w emulsion compositions
US20030018044A1 (en) * 2000-02-18 2003-01-23 Peyman Gholam A. Treatment of ocular disease
WO2002009667A2 (en) * 2000-07-28 2002-02-07 Pharmasol Gmbh Dispersions for formulating slightly or poorly soluble active ingredients
WO2002074196A1 (en) * 2001-03-15 2002-09-26 The United States of America, represented by The Secretary, Department of Health & Human Services Ocular therapeutic agent delivery devices and methods for making and using such devices
WO2003053405A1 (en) * 2001-11-01 2003-07-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method and composition for dry eye treatment
WO2003068253A1 (en) * 2002-02-14 2003-08-21 Merck Patent Gmbh Methods and compositions for the treatment of eye diseases
WO2004043480A2 (en) * 2002-11-07 2004-05-27 Peyman Gholam A Intraocular administration of cyclosporin a for the treatment of macular degeneration, retinopathy or retinitis pigmentosa

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ABDULRAZIK M ET AL: "OCULAR DELIVERY OF CYCLOSPORIN A II. EFFECT OF SUBMICRON EMULSION'S SURFACE CHARGE ON OCULAR DISTRIBUTION OF TOPICAL CYCLOSPORIN A", STP PHARMA SCIENCES, PARIS, FR, vol. 11, no. 6, 2001, pages 427 - 432, XP008033036, ISSN: 1157-1489 *

Also Published As

Publication number Publication date
WO2006003519A2 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
ATE439123T1 (en) USE OF EMULSIONS FOR INTRA- AND PERIOCULAR INJECTION
WO2006050002A3 (en) Compositions for controlled delivery of pharmaceutically active compounds
WO2006082588A3 (en) Method and device for ophthalmic administration of active pharmaceutical ingredients
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2007047948A3 (en) Intranasal administration of rapid acting insulin
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
WO2005065317A3 (en) Effervescent oral fentanyl dosage form
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
MX2009007742A (en) Multi-phasic pharmaceutical formulations of poorly water-soluble drugs for reduced fed/fasted variability and improved oral bioavailability.
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
WO2005112633A3 (en) Compounds and compositions for delivering active agents
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
BRPI0513455A (en) flavor masking formulation comprising the drug in a delayed dissolution form and / or cyclodextrin in an improved dissolution form
WO2008157103A3 (en) Modified release solid or semi-solid dosage forms
WO2006058140A3 (en) Capsaicinoid gel formulation and uses thereof
WO2005094799A3 (en) Use of an nmda receptor antagonist for the treatment of tinnitus induced by cochlear excitotoxicity
BRPI0519171A2 (en) ophthalmic drug delivery device
WO2006022996A3 (en) Dosage form containing multiple drugs
WO2008023016A3 (en) Galenic formulations of aliskiren
WO2005117895A3 (en) Compositions comprising meloxicam
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
WO2006076097A3 (en) Stable non-crystalline formulation comprising losartan
IL179177A (en) Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition
WO2005004860A3 (en) Novel solid pharmaceutical composition comprising amisulpride

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase